Profound Medical (PROF) Cash & Current Investments (2018 - 2026)

Profound Medical's Cash & Current Investments history runs 9 years deep, the most recent figure standing at $50.3 million for Q1 2026.

• On a quarterly basis, Cash & Current Investments rose 8.32% year-over-year to $50.3 million in Q1 2026; TTM through Mar 2026 was $50.3 million, a 8.32% increase from a year earlier, with the FY2025 full-year figure at $59.7 million, up 8.76% from the prior year.
• Cash & Current Investments eased to $50.3 million in Q1 2026 per PROF's latest filing, from $59.7 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $59.7 million in Q4 2025 and bottomed at $24.8 million in Q3 2025.
• The 5-year median for Cash & Current Investments is $46.5 million (2022), against an average of $43.0 million.
• Across the five-year window, Cash & Current Investments sank 43.65% in 2023 and jumped 109.48% in 2024, its largest moves.
• Year by year, Cash & Current Investments stood at $46.5 million in 2022, then slumped by 43.65% to $26.2 million in 2023, then jumped by 109.48% to $54.9 million in 2024, then climbed by 8.76% to $59.7 million in 2025, then declined by 15.79% to $50.3 million in 2026.
• Per Business Quant, the three latest PROF Cash & Current Investments figures stand at $50.3 million (Q1 2026), $59.7 million (Q4 2025), and $24.8 million (Q3 2025).